Contineum Therapeutics, Inc. · NASDAQ:CTNM
Perceptive Advisors LLC's stake in Contineum Therapeutics, Inc. fell to 3.20% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Perceptive Advisors LLC's stake in Contineum Therapeutics, Inc. fell to 3.20%, 699,486 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 3.20%
- Shares
- 699,486
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 3.20% | 699,486 |
| Joseph Edelman | 3.20% | 699,486 |
| Perceptive Life Sciences Master Fund, Ltd. | 3.20% | 699,486 |
Source
Related
- Contineum Therapeutics, Inc.
- Perceptive Advisors LLC
- Contineum Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Feb 14, 2025
- Schedule 13G · Trails Edge Capital Partners, LP · Oct 22, 2026
- Form 4 · Stengone Carmine N. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Stengone Carmine N. · Aug 3, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026